University of California, Davis: Prostatic Neoplasms trials
The registry lists 18 Prostatic Neoplasms studies with University of California, Davis as lead sponsor. 5 are open to participants now and 5 have results posted.
Phase 1 4Phase 2 6Phase 3 1No phase 8(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Comparison of New SUREcore Biopsy of Needle to Standard of Care During Transperineal Prostate BiopsiesRecruitingNCT06907446Not applicable
- Focal Ablation With Focal Cryotherapy or HIFU for the Treatment of Men With Localized Prostate CancerRecruitingNCT06178354Not applicable
- Abiraterone and Prednisone or Darolutamide for the Treatment of Advanced Prostate CancerRecruitingNCT06173362Phase 2
- Locally Ablative TherapY in Oligo-ProgressiVe GEnitourinary TumoRs (LAYOVER)RecruitingNCT06101290Not applicable
- A Pilot Study of Total-body PET Using FDA-approved Radiotracers Beyond 18F-FDGEnrolling by invitationNCT05160480
- Niraparib Before Surgery in Treating Patients With High Risk Localized Prostate Cancer and DNA Damage Response DefectsTerminatedNCT04030559Phase 2Results posted
- Cabazitaxel and Prednisone in Treating Patients With Metastatic Hormone-Resistant Prostate CancerTerminatedNCT02844582Phase 2Results posted
- Calcium-41 (41Ca) Chloride Aqueous Solution in Diagnosing Patients With Prostate Cancer and Bone MetastasisTerminatedNCT00918645Not applicableResults posted
- Use of Low Dose Ketoconazole in Prostate Cancer That Does Not Respond to Hormone Therapy and Prior ChemotherapyCompletedNCT00895310Phase 2Results posted
- Bicalutamide With or Without Everolimus in Treating Patients With Recurrent or Metastatic Prostate CancerCompletedNCT00814788Phase 2Results posted
- Geriatric Assessment and Promotores (GAP) Pilot Feasibility StudyCompletedNCT06125145Not applicable
- Enzalutamide and Niclosamide in Treating Patients With Recurrent or Metastatic Castration-Resistant Prostate CancerCompletedNCT03123978Phase 1
- Enzalutamide and Metformin Hydrochloride in Treating Patients With Hormone-Resistant Prostate CancerCompletedNCT02339168Phase 1
- Stereotactic Boost and Long-Term Androgen Deprivation for Adenocarcinoma of the ProstateCompletedNCT02064036Phase 1
- Diet, Genetic Variation and Prostate Cancer Among African AmericansCompletedNCT00584792
- Effects of a Genistein Concentrated Polysaccharide (GCP) for Prostate Cancer on Active Surveillance.CompletedNCT00584532Phase 2/3
- Effects of GCP on Prostate Cancer.CompletedNCT00269555Not applicable
- Monoclonal Antibody Therapy Plus Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone TherapyStatus unknownNCT00009750Phase 1